Atorvastatin calcium loaded PCL nanoparticles: development, optimization, in vitro and in vivo assessments-Reference-Cited by-同舟云学术

Atorvastatin calcium loaded PCL nanoparticles: development, optimization, in vitro and in vivo assessments

Published:2016 Issue:20 Volume:6 Page:16520-16532
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Kumar Nagendra¹²³⁴,Chaurasia Sundeep¹²³⁴,Patel Ravi R.¹²³⁴,Khan Gayasuddin¹²³⁴,Kumar Vikas¹²³⁴,Mishra Brahmeshwar¹²³⁴

Affiliation:

1. Department of Pharmaceutics

2. Indian Institute of Technology (Banaras Hindu University)

3. Varanasi-221005

4. India

Abstract

The aim of the present study was to prepare atorvastatin calcium (ATR) loaded poly(ε-caprolactone) nanoparticles (ALPNs) to enhance the oral bioavailability, efficacy and safety profile of drugs.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C5RA26674B

Reference49 articles.

1. Polymer nanoparticles: Preparation techniques and size-control parameters

2. Biodegradable polymeric nanoparticles as drug delivery devices

3. Polymeric nanocarriers for expected nanomedicine: current challenges and future prospects

4. Surface modified PMMA nanoparticles with tunable drug release and cellular uptake

5. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, optimization and characterization of atorvastatin loaded chitosan-based polyelectrolyte complex nanoparticles based transdermal patch;International Journal of Biological Macromolecules;2024-08

2. Ruxolitinib-loaded poly-ɛ-caprolactone (PCL) nanoparticles inhibit JAK2/STAT5 signaling in BT474 breast cancer cells by downregulating Bcl-2 and Mcl-1;Molecular Biology Reports;2024-07-22

3. Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins;Chemistry and Physics of Lipids;2024-05

4. Ruxolitinib-loaded poly-ɛ-caprolactone (PCL) nanoparticles inhibit the JAK2/STAT5 signaling via downregulating Bcl-2 and Mcl-1 on BT474 breast cancer cells;2024-04-24

5. Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin/Tween 80® nanocrystals formulated through wet milling and freeze-drying;International Journal of Pharmaceutics;2024-01